Get your full text copy in PDF
George B. Stefano
(Executive Vice President, International Scientific Information, Inc., Melville, USA)
Med Sci Monit 2017; 23:1856-1856
Since the realization that certain maladies can be corrected via surgical techniques, we have been consumed by the desire to constantly advance the tools of surgery, as well as the techniques. In recent times, computer-assisted surgical tools have emerged and are growing in their use. The Puma 560 emerged in 1985 for brain biopsies and laparoscopic surgery. Prostatic surgery was performed by the Probot in 1988. In 1992, fittings in the femur were placed using the ROBODOC. These early robotic endeavors gave rise to AESOP, ZEUS and the relatively intuitive da Vinci® Surgical System. These advances reflect the rapid growth of knowledge in the technology sector. These ever increasingly complex robotic-driven procedures are favored because this surgery provides a less invasive and therefore more tolerable “surgical” procedure for patients. In turn, these less invasive experiences may also allow for faster recovery times, reducing hospital stays and potentially costs. Importantly, this technology is accompanied by the development of more targeted surgical interventions. On the negative side, these technologies are initially expensive. However, as is always the case, there is hope that future devices will be more economical as more institutions invest. Another trend which may reduce costs is in the design of the robotic devices to incorporate a common central core of technology, to which other sub-devices can be attached, offering additional cost savings while enhancing flexibility.